Infection with bacterial species belonging to the Burkholderia cepacia complex contribute significantly to morbidity and mortality in persons with cystic fibrosis (CF). The majority of isolates recovered from CF patients belong to B. cepacia genomovar III and several distinct 'epidemic' strains have been described. This study examined the population structure of B. cepacia genomovar III by using multilocus restriction typing, indexing allelic variation at five chromosomal genes by restriction analysis of PCR-amplified genes. A collection of 375 isolates, recovered from CF and non-CF patients and natural environments in North America, Europe and Australia, was examined. Among these isolates 144 different restriction types were found. Overall, the population is at linkage disequilibrium, indicating that it has a clonal structure. The majority (86?7 %) of restriction types grouped into three major clonal complexes, comprising the epidemic ET12, PHDC and Midwest clonal lineages. The analysis indicates that these complexes are geographically widespread and demonstrate varying degrees of genetic recombination. These differences in population structure among major clonal complexes within the same species are likely related to differences in evolutionary history and ecology. The observation that genetic recombination is frequent within some B. cepacia genomovar III populations has important implications for the biotechnological use of B. cepacia complex species.
INTRODUCTION
Indexing of allelic variation in sets of chromosomal loci provides a basis for estimating overall levels of genotypic variation in populations of microorganisms (Musser, 1996) . Differences in the ratio of genetic change introduced by recombinational events relative to de novo mutation lead to a spectrum of population structures, from the extremes of strictly clonal (no recombination has occurred in the evolutionary history of the species, e.g. Salmonella enterica) to non-clonal or panmictic (recombinational events are frequent enough to randomize alleles in a population and prevent the emergence of stable clones, e.g. Helicobacter pylori). However, most bacterial populations occupy a middle ground where recombination is highly significant in the evolution of the population, but is not sufficiently frequent to prevent the emergence of epidemic clonal lineages (e.g. Neisseria meningitidis). Since bacterial populations are complex, single species may not always be adequately described by one model; mixtures of clonal and non-clonal elements within a given species are likely related to differences in ecology and epidemiology (Musser, 1996; Maiden et al., 1998; Spratt & Maiden, 1999; Day et al., 2001) . Insights into the structure of bacterial populations have proved valuable in enhancing our understanding of the biology of various human pathogenic species, including N. meningitidis, Staphylococcus aureus, Streptococcus pyogenes and Mycobacterium tuberculosis (Musser, 1996; Maiden et al., 1998; Spratt & Maiden, 1999; Day et al., 2001) .
Bacteria belonging to the Burkholderia cepacia complex [a group of nine phylogenetically closely related genomic species or genomovars Vandamme et al., 2002) ] are important opportunistic human pathogens in persons with cystic fibrosis (CF) or chronic granulomatous disease (Speert et al., 1994; Govan & Deretic, 1996; LiPuma, 1998; Johnston, 2001) . Infections in immunocompetent persons occur less frequently, but nosocomial outbreaks and pseudo-epidemics have been reported (LiPuma, 1998) . Recent studies demonstrate a markedly disproportionate representation of B. cepacia complex species among isolates recovered from CF patients, with the majority of isolates belonging to B. cepacia genomovar III Speert et al., 2002) . Infection with specific strains of this species may be associated with increased rates of morbidity and mortality (Aris et al., 2001; DeSoyza et al., 2001; Ledson et al., 2002) . Recent work has also identified B. cepacia genomovar III in the natural environment as a commensal of certain soil types and the rhizosphere of various plants (Balandreau et al., 2001; Fiore et al., 2001) .
Considerable evidence indicates that B. cepacia complex strains can spread between CF patients. This can occur via simultaneous hospital admission or social contact outside the hospital, and strict infection control measures are recommended to reduce the risk of patient-to-patient transmission (Govan & Deretic, 1996; LiPuma, 1998) . Nevertheless, several 'epidemic' strains have been described as infecting multiple patients. The ET12 clone, responsible for infecting many CF patients in Canada and the UK, is believed to have spread as a result of contact among infected patients at CF summer camps (Jonhson et al., 1994; Sun et al., 1995; Clode et al., 2000; Ledson et al., 2002) . Isolates belonging to this clone are characterized by distinctive cblAencoded cable pili (Sun et al., 1995) and esmR [also called the B. cepacia epidemic strain marker (BCESM)], a 1?4 kb putative ORF with homology to negative transcriptional regulators (Mahenthiralingam et al., 1997) . Infection with the ET12 clone has been associated with high rates of mortality (Ledson et al., 2002) and the so-called 'cepacia syndrome', which is characterized by sepsis and progressive respiratory failure (Isles et al., 1984) . Another epidemic clone, referred to as PHDC (Chen et al., 2001) , is responsible for nearly all B. cepacia complex infections in patients attending CF treatment centres in the mid-Atlantic region of the USA. PHDC isolates described to date contain neither cblA nor esmR (Chen et al., 2001) . Recently, isolates belonging to this clone have been recovered from agricultural soil samples suggesting that acquisition from the natural environment plays a significant role in the epidemiology of B. cepacia complex infection in CF . A third epidemic B. cepacia genomovar III clone, here referred to as the Midwest clone, is responsible for infecting numerous patients attending CF treatment centres in the midwestern region of the USA (LiPuma et al., 1988; Kumar et al., 1997) .
The relationships between these epidemic clones, between epidemic and seemingly unique strains, and between clinical and environmental isolates are not clear. A better appreciation of these relationships and the population structure of this species in general would provide critical insight into its epidemiology, evolution and ecology as a human pathogen. To date, the methods that have proved most useful in such studies have been multilocus enzyme electrophoresis (MLEE) and multilocus sequence typing (MLST), in which variation at several genomic loci is indexed through the electrophoretic mobility of the corresponding enzymes or by direct nucleotide sequencing, respectively (Musser, 1996; Maiden et al., 1998) . Previous studies documented the utility of MLEE to assess the molecular epidemiology of B. cepacia (McArthur et al., 1988; Johnson et al., 1994; Wise et al., 1995 Wise et al., , 1996 , but these were performed before the recognition that multiple species constitute the B. cepacia complex and most studies were limited to environmental isolates only.
We recently developed multilocus restriction typing (MLRT) as an alternate method for studying the global epidemiology of B. cepacia complex infection in CF . With MLRT, variation at chromosomal loci is indexed by restriction analysis of PCR-amplified genes. Using this method we previously identified several subgroups within B. cepacia genomovar III that seemed to be characterized by differences in rates of recombination. The aim of the present study was to expand these observations and examine in greater detail the population structure of B. cepacia genomovar III. We investigated 375 isolates recovered from various ecological niches, including CF and non-CF patients, and the natural environment in North America, Europe and Australia between 1966 and 2001.
METHODS
Sampling strategy. Three hundred and seventy-five B. cepacia genomovar III isolates were included in this study. These were obtained from clinical specimens [both CF (303 isolates) and non-CF (11 isolates)] from the USA (from 28 different states), Canada (from the provinces British Columbia, Alberta, Manitoba, Ontario, Quebec, Nova Scotia and Newfoundland) and Europe (the UK and Belgium). All isolates were from different patients and were isolated between 1966 and 2001. We also included 60 isolates recovered from the natural environment (including soil and plants) in the USA, Canada and Australia (the majority of environmental isolates were previously described by Balandreau et al., 2001 and LiPuma et al., 2002) . Isolates were selected [based on known epidemiology (i.e. geography) and genotyping data obtained in previous studies] to include sufficient numbers of the major epidemic lineages (ET12, PHDC and Midwest) previously identified and to include isolates that did not belong to any of the major groups (Kumar et al., 1997; Chen et al., 2001; LiPuma et al., 2001 LiPuma et al., , 2002 .
Growth conditions and identification of isolates. Strains were grown aerobically on Mueller-Hinton Broth (Becton Dickinson) supplemented with 1?8 % (w/v) agar and incubated at 32˚C. All isolates were identified by recA RFLP fingerprinting as described previously (Mahenthiralingam et al., 2000) . For isolates in which species identification remained equivocal following recA RFLP fingerprinting (i.e. if they belonged to RFLP types not previously described), complete recA nucleotide sequences were obtained to confirm that they belonged to B. cepacia genomovar III (Mahenhiralingam et al., 2000; LiPuma et al., 2001) . In addition, several isolates were confirmed to belong to B. cepacia genomovar III by extensive phenotypic characterization (Henry et al., 2001) , SDS-PAGE of whole-cell proteins and/or DNA-DNA hybridizations (Vandamme et al., 1997) as described previously.
Multilocus restriction typing. DNA preparation, PCR amplification of nearly complete sequences of the recA, gyrB, fliC, cepIR and dsbA genes, enzymic restriction digests and separation of the resulting restriction fragments were performed as described previously .
Data analysis. Gel images were digitized using a GelDoc 2000 (Bio-Rad) and stored as TIFF files. Digitized images were converted and normalized with Molecular Analyst Fingerprinting Plus software (Bio-Rad). Following normalization we defined a set of bands to each normalized densitometric curve. Similarity between the patterns was calculated using the Dice coefficient as implemented in the Molecular Analyst Fingerprinting Plus software (both tolerance and optimization parameters were set to 1?0 %). Restriction patterns for each locus were considered to be the same if they had the same number of bands and if they demonstrated at least 92 % similarity following cluster analysis using the above-defined parameters. Different restriction patterns for each locus were considered to represent different alleles and each allele was assigned an arbitrary integer. The allelic profile for each isolate (consisting of the allele designation for each locus) was entered into a Microsoft Excel database; each unique allelic profile was assigned an arbitrary integer [restriction type (RT)]. The START software package (Jolley et al., 2001 ) was used to group the allelic profiles using the BURST algorithm and convert the dataset to a distance matrix in NEXUS format. Distance matrices were used for split decomposition analysis (Bandelt & Dress, 1992; Dopazo et al., 1993) using SplitsTree 3.1 (Huson, 1998) . Where necessary, higher resolution of the splits graph was obtained by progressively pruning resolved branches. The standardized index of association (sI A ), mean genetic diversity (H mean ) and genetic diversity at each locus were calculated using the LIAN 3.1 software package (Haubold & Hudson, 2000) . Difference from linkage equilibrium was statistically tested by a previously described parametric method (Haubold et al., 1998) as implemented in LIAN 3.1 (Haubold & Hudson, 2000) .
Detection of genes encoding putative transmissibility factors. Isolates were analysed by dot-blot hybridizations and/or PCR for the presence of cblA and esmR as described previously (Mahenthiralingam et al., 1997; Chen et al., 2001; LiPuma et al., 2001) .
RESULTS
Diversity of recA, gyrB, fliC, cepIR and dsbA genes
The chromosomal loci studied ranged in length from 1043 bp (recA) to 2160 bp (cepIR) and the number of different alleles present per locus ranged from 13 (recA) to 72 (dsbA) ( Table 1) . The frequency with which each allele occurred in the sample population is shown in Fig. 1 ; the genetic diversity (H) at each locus is shown in Table 1 .
RTs and clonal complexes
A total of 144 RTs were found among the 375 B. cepacia genomovar III isolates examined (Table 2) . To group RTs into clusters of closely related RTs (clonal complexes) we used the BURST algorithm (Day et al., 2001; . Using this algorithm, clonal complexes were defined as groups in which each isolate is identical to at least one other isolate at three or more of the five loci. In addition, within each major clonal complex we identified the putative ancestral genotype as the RT differing from the highest number of other RTs within the complex at only one locus. We then identified so-called 'single-locus variants' (SLVs) (differing from the ancestral genotype at one locus), 'double-locus variants' (DLVs) (differing from the ancestral genotype at two loci) and satellite RTs (defined as a member of the clonal complex but not an ancestral genotype or an SLV or DLV of the ancestral genotype). Secondary ancestral genotypes are SLVs of the ancestral genotype that in turn define more SLVs that have not been previously defined.
Most of the isolates (n5354, 94?4 %) grouped into one of 11 clonal complexes, while 21 isolates belonged to 19 RTs that differ from all other genotypes at more than two loci (singleton RTs) ( Table 2 ). The majority of isolates (n5325, 86?7 %) clustered in three major clonal complexes designated RT-6-complex, RT-46-complex and RT-88-complex (clonal complexes are named after their putative ancestral genotype). The relationships between RTs belonging to these three major complexes, as determined by using the BURST algorithm and split decomposition analysis, are shown in Fig. 2 .
Measures of association
We calculated the sI A for all isolates and for all RTs; the values obtained (0?3295 and 0?1752, respectively) were both significantly different from 0 (P,0?0001) (Table 3) , suggesting a clonal population structure. However, when we calculated the sI A for the three major clonal complexes separately, we found significant differences in population structure (Table 3, Fig. 2) . The RT-6-complex shows evidence of an epidemic population structure: sI A .0 for the whole dataset but the evidence of association disappears when each RT is treated as a single individual entry. The population structure of the RT-88-complex shows evidence of clonality at all levels (sI A .0), while the opposite is true for the RT-46-complex.
Distribution of genes encoding putative transmissibility factors
The distribution of cblA and esmR is shown in Table 2 . Positive results for cblA were only obtained with isolates belonging to the RT-6-complex. Specifically, most were representatives of the ET12 clone (comprising RT-5 and RT-17); however, low-proficiency amplification of cblA was observed in several representatives of other RTs belonging to the RT-6-complex. Isolates that were positive for esmR were found in the majority of RTs belonging to either the RT-6-complex or the respectively) . However, only 27?9 % of the RTs belonging to the RT-88-complex contained isolates that were positive for esmR. The sI A values for all isolates and for all RTs were significantly different from 0. This suggests that the overall population has a clonal structure, that recombination within the total population has been relatively rare and that the population is at linkage disequilibrium (Maynard Smith et al., 1993) .
Subpopulations within B. cepacia genomovar III
Our data clearly show different subpopulations among the B. cepacia genomovar III isolates studied. The RT-6-complex (which contains RT-5 and RT-17, the RTs comprising representatives of the trans-Atlantic ET12 clone) was characterized by an sI A significantly different from 0, indicative of linkage disequilibrium (Table 3) . However, when the analysis was repeated with each RT treated as an individual, the evidence for linkage disequilibrium disappeared, indicating an epidemic population structure. This provides strong evidence that this subpopulation is recombining in the long term but that a few RTs have recently become abundant and widespread (Maynard Smith et al., 1993) . Using the BURST algorithm, RT-6 was designated as the ancestral genotype; RT-21, RT-31 and RT-41 were designated as secondary ancestral genotypes (Fig. 2) . The most frequent RT is RT-17, which contained 28 isolates belonging to the ET12 clone (recovered from CF patients in Canada, the UK and the USA). The ET12 clone was first described in 1984 (Isles et al., 1984) and our data suggest that its recent worldwide dissemination contributes significantly to the epidemic population structure of the RT-6-complex.
Isolates belonging to the RT-46-complex were mostly isolated in the Midwestern region of the USA (87?2 % of all isolates were from Michigan or Ohio), but were also recovered from single CF patients in North Carolina, Washington and Pennsylvania. The sI A within this clonal complex was not significantly different from 0 (Table 3) , indicating that this subpopulation is at linkage equilibrium (Maynard Smith et al., 1993) . The putative ancestral genotype (RT-46) also was the most frequent, containing 71?8 % of all isolates.
In contrast to the other major clonal complexes, the population structure of the RT-88-complex showed linkage disequilibrium at all levels (sI A is significantly different from 0, even when RTs are treated as individual entries) ( Table 3 ). This clonal complex comprised several RTs that contained both isolates recovered from CF patients and isolates recovered from soil. We have previously shown that these isolates belong to the PHDC lineage (Chen et al., 2001; LiPuma et al., 2002) . The data from the present study showed that this lineage is not restricted to the mid-Atlantic region of the USA but is much more widespread ( Table 2 ).
The underlying reasons for the observed differences in population structure among the major clones within B. cepacia genomovar III are at present unclear. The frequency of recombinational events is determined by the availability and efficiency of genetic exchange mechanisms (including transformation, transduction and conjugation) and by ecological factors (different strains must be present within the same niche) . The distribution of the various exchange mechanisms among different B. cepacia genomovar III lineages is largely unknown, although most members of the B. cepacia complex (including representatives of the ET12 clone) are sensitive to transducing bacteriophages (Nzula et al., 2000) . It has also been reported that the genome of B. cepacia complex organisms is rich in insertion sequences that may promote genomic rearrangements and recruit foreign genes (Lessie et al., 1996; Tyler et al., 1996) . Our data indicate that isolates belonging to different RTs can be recovered from the same soil samples (data not shown). In contrast, data regarding co-colonization of CF patients with multiple genotypes are limited. The observation that the RT-88-complex is clonal suggests that it has a reduced ability to exchange genetic material with other lineages, that it is spatially isolated from other lineages, or both. Elucidation of the distribution of genetic exchange mechanisms and the extent of mixed infections would allow a better appreciation of how these factors might contribute to the observed differences in population structure detected within B. cepacia genomovar III.
Distribution of genes encoding putative transmissibility factors
cblA and esmR are markers that have been associated with B. cepacia complex strains for which there is evidence of interpatient spread (Sun et al., 1995; Mahenthiralingam et al., 1997) . However, the exact role and function of these putative transmissibility factors and their distribution within the B. cepacia complex population have yet to be determined. cblA has been found primarily in the ET12 clone and a limited number of other B. cepacia genomovar III strains (Sun et al., 1995; Clode et al., 2000; Speert et al., 2002) . Recently, however, several B. cepacia genomovar I strains possessing a variant of this gene were described . In this study we found that the presence of cblA was limited to members of the RT-6-complex, most notably representatives of the ET12 clone (RT-5 and RT-17). Isolates belonging to several other RTs within the RT-6-complex (mostly SLVs of RT-17 and/or RT-5) reacted with the primers used for the PCR amplification of cblA but the resulting PCR product was very weak. There is considerable sequence variation in cblA of B. cepacia complex isolates belonging to different species or lineages (Sun et al., 1995; Richardson et al., 2001) and sequence variation in the primer-binding regions of cblA might explain the low-proficiency PCR amplification observed in this study.
esmR has previously been found in isolates belonging to the ET12 clone as well as other epidemic lineages and in several non-epidemic isolates (including isolates belonging to Burkholderia multivorans and B. cepacia genomovar I) (Mahenthiralingam et al., 1997; Clode et al., 2000; Speert et al., 2002) but not in the PHDC clone (Chen et al., 2001) . Our data show that esmR is widespread both in the RT-6 and RT-46-complexes, but is much less frequent in the RT-88-complex or any of the smaller clonal complexes (Table 2 ). In addition, esmR appears to be unstable, since there are several RTs that contain both isolates in which this marker is present and isolates in which it is absent (data not shown). Instability of the genomic region containing esmR was already suggested by Mahenthiralingam et al. (1997) . (Chen et al., 2001) . The fact that other RTs are also common to CF patients and soil samples suggests that there may have been multiple acquisitions from the environment.
Our observation that environmental B. cepacia genomovar III strains can be found in several clonal complexes but not in the RT-6-or RT-46-complex, raises questions about the origin of these two major clonal complexes. Indeed, a recent study looking for B. cepacia genomovar III in the environment failed to recover isolates belonging to either of these two complexes, despite the fact that samples were taken in the same geographic region as where the majority of the RT-6-and RT-46-complex infected patients reside (our unpublished data). A possible explanation for this is that the sites surveyed were significantly different from the agricultural soils surveyed in other studies (Balandreau et al., 2001; LiPuma et al., 2002) and may not be a suitable ecological niche for B. cepacia genomovar III. Nevertheless, initial acquisition of RT-6-complex organisms from the environment probably occurred with an isolate resembling RT-6; subsequent mutations and recombination then gave rise to the ET12 clone which seems to have spread epidemically through the CF population. The fact that cblA is predominantly found in RT-6 and SLVs of RT-6 suggests an important role for this gene in the rapid spread of this group of organisms. Similarly, the initial acquisition of RT-46-complex organisms from the environment most likely occurred with an isolate resembling RT-46. The finding of singleton RTs, and the fact that several minor clonal complexes contain isolates recovered both from the environment and from clinical samples (Table 2) also support the hypothesis of frequent environmental acquisition of B. cepacia genomovar III.
Implications for biotechnological use of B. cepacia complex organisms
Besides being human pathogens, members of the B. cepacia complex have also attracted considerable attention as biocontrol and bioremediation agents. However, the potential hazard of these strains to the CF community is unclear (Holmes et al., 1998; Parke & Gurian-Sherman, 2001 ). Our data show that the possibility of recombination exists in at least two major clonal complexes of B. cepacia genomovar III and this potential for gene transfer may have important implications for the biotechnological use of B. cepacia complex strains (Parke & Gurian-Sherman, 2001 ). Whether or not this potential for gene transfer can be extended to other members of the B. cepacia complex remains to be determined, but it is worth noting that interspecies recombinational events have previously been described in other genera, including Neisseria, Salmonella and Streptococcus (Dowson et al., 1990; Bowler et al., 1994; Lan & Reeves, 1996) .
Implications for infection control
To reduce the risk of B. cepacia complex spreading from patient to patient, stringent infection control measures (including segregation of colonized patients) are recommended (Govan & Deretic, 1996; LiPuma, 1998) . Our data and results from previous work Balandreau et al., 2001; LiPuma et al., 2002) suggest that environmental acquisition of 'epidemic' B. cepacia genomovar III strains may be more common than previously assumed. In cases where good infection control practices do not drastically reduce or eliminate new B. cepacia complex infections, environmental acquistion of this organism should be considered. Recently it was suggested that infection control strategies should be based on the presence or absence of several markers, including cblA and esmR (Clode et al., 2000) , but this seems ill-advised since some transmissible strains do not contain either of these markers (Chen et al., 2001) . Our data confirm that the presence of cblA and/or esmR are of limited value to predict virulence or transmissibility, since (i) they are not found in all epidemic lineages, (ii) they are not stable within a given lineage and (iii) variation in the sequence of these putative transmissibility markers may complicate their accurate detection.
